Curated Business Corporate News

NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.

March Bio's Cancer Therapy Gets FDA RMAT Designation

November 11, 2025March Biosciences receives FDA RMAT designation for MB-105 CAR-T therapy targeting T-cell lymphoma. Accelerated development pathway for novel cancer treatment addressing unmet medical need.